期刊文献+

17α-羟化酶缺陷症诊治研究进展 被引量:7

Research progress of diagnosis and treatment of 17α-hydroxylase deficiency
原文传递
导出
摘要 17α-羟化酶缺陷症(17OHD)是由编码17α-羟化酶(P450c17酶)的CYP17A1基因突变所致肾上腺皮质激素和性激素合成障碍的一种罕见常染色体隐性遗传病。高血压、低钾血症、性发育异常等为其主要表现,由于该疾病临床表现复杂多样,患者早期症状不典型,临床上误诊率和漏诊率高。结合目前最新的研究证据,介绍17OHD的流行病学、病因和发病机制、临床表现、诊断和鉴别诊断、治疗和预后,可加深对该疾病的认识,从而更好的指导临床工作。 17α-hydroxylase deficiency(17OHD)is a rare autosomal recessive disease of adrenocortical hormone and sex hormone synthesis disorder caused by mutation of CYP17A1 gene encoding 17-αhydroxylase(P450c17 enzyme).The disease characterized by hypertension,hypokalemia and disorders of sex development.Due to complicated manifestation and untypical early symptom,the misdiagnosis rate and missed diagnosis rate are high.According to the latest research evidence,the epidemiology,etiology and pathogenesis,clinical manifestations,diagnosis and differential diagnosis,treatment and prognosis of 17OHD are introduced,which aims to better guide clinical work through the profound understanding of 17OHD.
作者 马婧 杜雅丽 权金星 Ma Jing;Du Yali;Quan Jinxing(Department of Endocrinology and Metabolism,Gansu Provincial Hospital,iMnzhou 730000,China;Department of Ophthalmology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China)
出处 《国际内分泌代谢杂志》 2020年第5期323-326,共4页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金(81860091)。
关键词 17Α-羟化酶缺陷症 先天性肾上腺皮质增生症 高血压 低钾血症 17α-hydroxylase deficiency Congenital adrenal hyperplasia Hypertension Hypokalemia
  • 相关文献

参考文献7

二级参考文献79

  • 1陶红,陆召麟,张波,王玥,孙梅励.17α-羟化酶/17,20-裂解酶缺陷症的临床特点及长期随诊资料分析[J].中华内科杂志,2005,44(6):442-445. 被引量:32
  • 2杨军,李小英,孙首悦,乔洁,赵咏桔,刘建民,宁光,许曼音,陈家伦.10例17α羟化酶/17,20碳链裂解酶缺陷症临床和遗传学研究[J].上海交通大学学报(医学版),2006,26(1):17-21. 被引量:22
  • 3杨明辉,吴新宝,李庭,王满宜.17α-羟化酶缺陷症临床及分子遗传学研究[J].中华医学杂志,2006,86(41):2900-2904. 被引量:12
  • 4Speiser PW, White PC. Congenital adrenal hyperplasia [ J]. N Engl J Med, 2003, 349 (8): 776-788.
  • 5Costa- Santos M, Kater CE, Auchus RJ, et al. Two pevalent CYP17 mutations and genotype phenotype correlations in 24 Brazilian patients with 17 -cthydroxylase deficiency [J]. Clin Endocrinol Metab, 2004, 89 (1): 49-60.
  • 6Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency : Endocrine Society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2010, 95 (9) : 41334160. DOI: 10. 1210/ jc. 2009-2631.
  • 7Miller WL. Moleeular biology of steroid hormone synthesis [ J]. Endoer Rev, 1988, 9(3) :295-318.
  • 8Gidl6f S, Wedell A, Guthenberg C, et al. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden a 26-year longitudinal prospective population-based study [ J ]. JAMA Pediatr, 2014, 168 ( 6 ): 567-574. DOI: 10. 1001/ jamapediatries. 2013. 5321.
  • 9Sharma R, Seth A. Congenital adrenal hyperplasia: issues in diagnosis and treatment in children[ J]. Indian J Pediatr, 2014, 81 : (2) :178-185. DOI: 10. 1007/s120984313-1280-8.
  • 10Forest MG. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J]. Hum Reprod Update, 2004,10(6) :469-485.

共引文献98

同被引文献41

引证文献7

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部